No statistically significant relationships were found, however, between the expression of CD200 and CD200R molecules on the surface of T lymphocytes (CD4+ and CD8+) and B lymphocytes (CD19 +) and the analyzed clinical and laboratory parameters in patients with particular types of PAH. This evidence concerns the gene CD19 and pulmonary arterial hypertension.